• | the assets and liabilities aligned with the company’s materials science business (including Historical DuPont’s ethylene and ethylene copolymers business, excluding its ethylene acrylic elastomers business, (“ECP”) were transferred or conveyed to separate legal entities (the “DuPont Materials Science entities") that were ultimately conveyed by DowDuPont to Dow; |
• | the assets and liabilities aligned with Historical DuPont’s specialty products business were transferred or conveyed to separate legal entities (the "DuPont Specialty Products entities"); |
• | on April 1, 2019, Historical DuPont transferred and conveyed the DuPont Materials Science entities to DowDuPont; |
• | on May 1, 2019, Historical DuPont distributed the DuPont Specialty Products entities to DowDuPont; and |
• | on May 2, 2019, DowDuPont conveyed the Dow AgroSciences entities to Historical DuPont; in connection with the foregoing, Historical DuPont issued additional shares of its Common Stock to DowDuPont. |
• | The unaudited pro forma combined balance sheet as of December 31, 2018 gives effect to the Internal Reorganization, Debt Retirement Transactions and the Corteva Distribution as if they had been consummated on December 31, 2018. |
• | The unaudited pro forma combined statements of operations for the years ended December 31, 2018, 2017 and 2016 give effect to the Merger, the Internal Reorganization, Debt Retirement Transactions and the Corteva Distribution as if they had been consummated on January 1, 2016. |
(in millions) | Successor Historical DuPont Continuing Operations(1) | Separation and Debt Retirement Pro Forma Adjustments | Pro Forma Historical DuPont | |||||||
Assets | Note 5 | Note 3 | ||||||||
Current assets | ||||||||||
Cash and cash equivalents | $ | 2,269 | $ | (141 | ) | (i) | $ | 2,128 | ||
Marketable securities | 5 | — | 5 | |||||||
Accounts and notes receivable – net | 5,355 | 54 | (a)(e) | 5,409 | ||||||
Inventories | 5,260 | (10 | ) | (a) | 5,250 | |||||
Other current assets | 1,044 | — | 1,044 | |||||||
Total current assets | 13,933 | (97 | ) | 13,836 | ||||||
Investment in nonconsolidated affiliates | 138 | — | 138 | |||||||
Net property | 4,533 | — | 4,533 | |||||||
Goodwill | 10,193 | — | 10,193 | |||||||
Other intangible assets | 12,055 | — | 12,055 | |||||||
Deferred income tax assets | 306 | (11 | ) | (d) | 295 | |||||
Other assets | 1,830 | — | 1,830 | |||||||
Total assets | $ | 42,988 | $ | (108 | ) | $ | 42,880 | |||
Liabilities and Equity | ||||||||||
Current liabilities | ||||||||||
Short-term borrowings and capital lease obligations | $ | 2,153 | $ | (264 | ) | (j) | $ | 1,889 | ||
Accounts payable | 3,804 | (21 | ) | (a) | 3,783 | |||||
Income taxes payable | 187 | (38 | ) | (e) | 149 | |||||
Accrued and other current liabilities | 4,016 | 157 | (a) (b)(e)(l) | 4,173 | ||||||
Total current liabilities | 10,160 | (166 | ) | 9,994 | ||||||
Long-term debt | ||||||||||
Long-term debt | 5,784 | (5,605 | ) | (j) | 179 | |||||
Long-term debt – related party | — | 5,771 | (k) | 5,771 | ||||||
Total long-term debt | 5,784 | 166 | 5,950 | |||||||
Other noncurrent liabilities | ||||||||||
Deferred income tax liabilities | 1,475 | 26 | (m) | 1,501 | ||||||
Pension and other postemployment benefits – noncurrent | 5,676 | (71 | ) | (d) | 5,605 | |||||
Other noncurrent obligations | 1,780 | (3 | ) | (c) | 1,777 | |||||
Total noncurrent liabilities | 14,715 | 118 | 14,833 | |||||||
Stockholders’ equity | ||||||||||
Preferred stock | 239 | — | 239 | |||||||
Common stock | — | — | — | |||||||
Additional paid-in capital | 20,201 | — | 20,201 | |||||||
Retained earnings (accumulated deficit) | 59 | (60 | ) | (q) | (1 | ) | ||||
Accumulated other comprehensive loss | (2,412 | ) | — | (2,412 | ) | |||||
Total stockholders’ equity | 18,087 | (60 | ) | 18,027 | ||||||
Noncontrolling interests | 26 | — | 26 | |||||||
Total equity | 18,113 | (60 | ) | 18,053 | ||||||
Total liabilities and equity | $ | 42,988 | $ | (108 | ) | $ | 42,880 | |||
(in millions) | Successor Historical DuPont Continuing Operations(1) | Pro Forma Adjustments | Pro Forma Historical DuPont | |||||||
Note 5 | ||||||||||
Net sales | $ | 14,287 | $ | — | 3(a) | $ | 14,287 | |||
Cost of goods sold | 10,020 | (1,499 | ) | 3(a) 3(g) 4(b) | 8,521 | |||||
Research and development expense | 1,435 | (3 | ) | 3(a) | 1,432 | |||||
Selling, general and administrative expenses | 2,901 | 1 | 3(a) 3(g) | 2,902 | ||||||
Amortization of intangibles | 391 | — | 391 | |||||||
Restructuring and asset-related charges – net | 694 | — | 694 | |||||||
Integration and separation costs | 992 | (421 | ) | 3(f) | 571 | |||||
Goodwill impairment charge | 4,503 | — | 4,503 | |||||||
Sundry income – net | 249 | — | 249 | |||||||
Loss on early extinguishment of debt | 81 | (81 | ) | 3(n) | — | |||||
Interest expense | 337 | (14 | ) | 3(o) | 323 | |||||
(Loss) income from continuing operations before income taxes | (6,818 | ) | 2,017 | (4,801 | ) | |||||
(Benefit from) provision for income taxes on continuing operations | (34 | ) | 385 | 3(a) 3(f) 3(g) 3(h) 3(p) 4(g) | 351 | |||||
(Loss) income from continuing operations after income taxes | (6,784 | ) | 1,632 | (5,152 | ) | |||||
Net income from continuing operations attributable to noncontrolling interests | 19 | — | 19 | |||||||
Net (loss) income from continuing operations attributable to Historical DuPont | $ | (6,803 | ) | $ | 1,632 | $ | (5,171 | ) | ||
(in millions) | Predecessor Historical DuPont Continuing Operations(1) | Dow AgroSciences(2) | Successor Historical DuPont Continuing Operations(3) | Dow AgroSciences Adjustments | Merger Pro Forma Adjustments | Adjusted Historical DuPont Continuing Operations | Separation and Debt Retirement Pro Forma Adjustments | Pro Forma Historical DuPont | ||||||||||||||||||
Note 5 | Note 5 | Note 2 | Note 4 | (subtotal) | Note 3 | |||||||||||||||||||||
Net sales | $ | 6,954 | $ | 3,761 | $ | 3,785 | $ | (200 | ) | $ | (60 | ) | (a) | $ | 14,240 | $ | — | (a) | $ | 14,240 | ||||||
Cost of goods sold | 3,591 | 2,485 | 2,936 | (200 | ) | (465 | ) | (a)(b)(c) | 8,347 | 55 | (a) (g) | 8,402 | ||||||||||||||
Research and development expense | 634 | 370 | 511 | (14 | ) | 10 | (c) | 1,511 | (2 | ) | (a) | 1,509 | ||||||||||||||
Selling, general and administrative expenses | 1,542 | 538 | 870 | 10 | 11 | (c) | 2,971 | 1 | (a) (g) | 2,972 | ||||||||||||||||
Amortization of intangibles | 40 | 11 | 97 | — | 122 | (d) | 270 | — | 270 | |||||||||||||||||
Restructuring and asset-related charges (benefits) – net | 12 | (1 | ) | 270 | — | (10 | ) | (e) | 271 | — | 271 | |||||||||||||||
Integration and separation costs | 354 | — | 255 | 25 | (168 | ) | (e) | 466 | (249 | ) | (f) | 217 | ||||||||||||||
Sundry (expense) income – net | (597 | ) | (428 | ) | 805 | (679 | ) | — | (899 | ) | — | (899 | ) | |||||||||||||
Interest expense | 254 | 2 | 115 | — | (80 | ) | (f) | 291 | 30 | (o) | 321 | |||||||||||||||
(Loss) income from continuing operations before income taxes | (70 | ) | (72 | ) | (464 | ) | (700 | ) | 520 | (786 | ) | 165 | (621 | ) | ||||||||||||
(Benefit from) provision for income taxes on continuing operations | (430 | ) | (12 | ) | (2,207 | ) | (238 | ) | 173 | (g) | (2,714 | ) | (318 | ) | (a)(f)(g)(h)(p) | (3,032 | ) | |||||||||
Income (loss) from continuing operations after income taxes | 360 | (60 | ) | 1,743 | (462 | ) | 347 | 1,928 | 483 | 2,411 | ||||||||||||||||
Net income from continuing operations attributable to noncontrolling interests | 1 | 17 | 7 | — | — | 25 | — | 25 | ||||||||||||||||||
Net income (loss) from continuing operations attributable to Historical DuPont | $ | 359 | $ | (77 | ) | $ | 1,736 | $ | (462 | ) | $ | 347 | $ | 1,903 | $ | 483 | $ | 2,386 | ||||||||
(in millions) | Predecessor Historical DuPont Continuing Operations(1) | Dow AgroSciences | Dow AgroSciences Adjustments | Merger Pro Forma Adjustments | Adjusted Historical DuPont Continuing Operations | Separation and Debt Retirement Pro Forma Adjustments | Pro Forma Historical DuPont | ||||||||||||||||
Note 5 | As Reported | Note 2 | Note 4 | (subtotal) | Note 3 | ||||||||||||||||||
Net sales | $ | 8,265 | $ | 6,144 | $ | (290 | ) | $ | (78 | ) | (a) | $ | 14,041 | $ | — | (a) | $ | 14,041 | |||||
Cost of goods sold | 4,603 | 4,020 | (225 | ) | (49 | ) | (a)(c) | 8,349 | 42 | (a)(g) | 8,391 | ||||||||||||
Research and development expense | 925 | 586 | (15 | ) | 15 | (c) | 1,511 | (4 | ) | (a) | 1,507 | ||||||||||||
Selling, general and administrative expenses | 2,066 | 845 | 8 | 17 | (c) | 2,936 | 1 | (a)(g) | 2,937 | ||||||||||||||
Amortization of intangibles | 45 | 18 | — | 184 | (d) | 247 | — | 247 | |||||||||||||||
Restructuring and asset-related charges – net | 438 | 11 | 4 | — | 453 | — | 453 | ||||||||||||||||
Integration and separation costs | 285 | — | 27 | (147 | ) | (e) | 165 | (91 | ) | (f) | 74 | ||||||||||||
Sundry expense – net | (48 | ) | (18 | ) | (7 | ) | — | (73 | ) | — | (73 | ) | |||||||||||
Interest expense | 370 | 7 | — | (120 | ) | (f) | 257 | 91 | (o) | 348 | |||||||||||||
(Loss) income from continuing operations before income taxes | (515 | ) | 639 | (96 | ) | 22 | 50 | (39 | ) | 11 | |||||||||||||
(Benefit from) provision for income taxes on continuing operations | (275 | ) | (48 | ) | (33 | ) | 9 | (g) | (347 | ) | (12 | ) | (a)(f)(g)(p) | (359 | ) | ||||||||
(Loss) income from continuing operations after income taxes | (240 | ) | 687 | (63 | ) | 13 | 397 | (27 | ) | 370 | |||||||||||||
Net income from continuing operations attributable to noncontrolling interests | 1 | 14 | — | — | 15 | — | 15 | ||||||||||||||||
Net (loss) income from continuing operations attributable to Historical DuPont | $ | (241 | ) | $ | 673 | $ | (63 | ) | $ | 13 | $ | 382 | $ | (27 | ) | $ | 355 | ||||||
(in millions) | Amount | ||
5.750% Senior Notes due 2019 | $ | 500 | |
4.625% Senior Notes due 2020 | 1,000 | ||
3.625% Notes due 2021 | 1,000 | ||
4.250% Notes due 2021 | 500 | ||
2.800% Notes due 2023 | 1,250 | ||
6.500% Debentures due 2028 | 300 | ||
5.600% Senior Notes due 2036 | 400 | ||
4.900% Notes due 2041 | 500 | ||
4.150% Notes due 2043 | 750 | ||
Total | $ | 6,200 | |
(in millions) | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||
Net sales | $ | (200 | ) | $ | (290 | ) |
Cost of goods sold | (144 | ) | (166 | ) | ||
Research and development expense | (12 | ) | (12 | ) | ||
Selling, general and administrative expenses | (23 | ) | (23 | ) | ||
Sundry (expense) income – net | (679 | ) | (7 | ) | ||
Income from continuing operations before income taxes | (700 | ) | (96 | ) | ||
Provision for income taxes on continuing operations | (238 | ) | (33 | ) | ||
Income from continuing operations after income taxes | $ | (462 | ) | $ | (63 | ) |
(in millions) | For the Period January 1 - August 31, 2017 | For the Year Ended December 31, 2016 | ||||||||||
Cost of goods sold | $ | — | $ | (2 | ) | |||||||
Selling, general and administrative expenses | $ | — | $ | (2 | ) | |||||||
Restructuring and asset-related charges – net | $ | — | $ | 4 | ||||||||
Cost of goods sold | $ | (13 | ) | $ | (12 | ) | ||||||
Research and development expense | $ | (2 | ) | $ | (3 | ) | ||||||
Selling, general and administrative expenses | $ | (10 | ) | $ | (12 | ) | ||||||
Integration and separation costs | $ | 25 | $ | 27 | ||||||||
Cost of goods sold(1) | $ | (43 | ) | $ | (45 | ) | ||||||
Selling, general and administrative expenses(1) | $ | 43 | $ | 45 | ||||||||
(a) | The Telone® Soil Fumigant business (“Telone®”) will not transfer to Historical DuPont as part of the common control combination of Dow AgroSciences. A distribution agreement was entered into, that allows for the DAS Legal Entities to become the exclusive distributor of Telone® products for Dow after the separation and distribution transactions. This adjustment reflects the impact to the pro forma financial statements of the removal of Telone® balances that will not transfer to Historical DuPont as well as the impact of the Telone® distribution agreement. |
(in millions) | As of December 31, 2018 | ||
Accounts and notes receivable – net | $ | (125 | ) |
Inventories | (10 | ) | |
Total assets | $ | (135 | ) |
Accounts payable | $ | (21 | ) |
Accrued and other current liabilities | (68 | ) | |
Total liabilities | $ | (89 | ) |
(in millions) | For the Year Ended December 31, 2018 | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||||
Net sales | $ | (151 | ) | $ | (149 | ) | $ | (145 | ) |
Cost of goods sold | (54 | ) | (51 | ) | (61 | ) | |||
Research and development expense | (3 | ) | (2 | ) | (4 | ) | |||
Selling, general and administrative expenses | (18 | ) | (18 | ) | (18 | ) | |||
Income from continuing operations before income taxes | (76 | ) | (78 | ) | (62 | ) | |||
Provision for income taxes on continuing operations(1) | (19 | ) | (19 | ) | (15 | ) | |||
Income from continuing operations after income taxes | $ | (57 | ) | $ | (59 | ) | $ | (47 | ) |
(in millions) | For the Year Ended December 31, 2018 | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||||
Net sales | $ | 151 | $ | 149 | $ | 145 | |||
Cost of goods sold | 98 | 97 | 94 | ||||||
Selling, general and administrative expenses | 15 | 15 | 15 | ||||||
Income from continuing operations before income taxes | 38 | 37 | 36 | ||||||
Provision for income taxes on continuing operations(1) | 9 | 9 | 9 | ||||||
Income from continuing operations after income taxes | $ | 29 | $ | 28 | $ | 27 | |||
(b) | Adjustment to include a $63 million amount due to Dow related to an indemnification outlined in the Separation Agreement. |
(c) | Adjustment to remove $3 million of liabilities related to litigation matters that are included in the financial statements of Dow AgroSciences, but will not transfer as part of the common control combination. |
(d) | Adjustment reflects removal of $71 million of pension and other employee liabilities and $11 million of related deferred tax assets that will not transfer in connection with the separation. |
(e) | Adjustment to include indemnification receivables and payables of $193 million recorded to accounts and notes receivable - net and $203 million recorded to accrued and other current liabilities, respectively, required under the terms of the tax matters agreement as well as to remove historical income tax receivables and payables of $14 million from accounts and notes receivable - net and $38 million from income taxes payable, respectively, for Dow AgroSciences that will not transfer as part of the common control combination. |
(f) | Adjustment to eliminate one-time transaction costs directly attributable to the expected distribution transactions. The below represents the impact to the respective unaudited pro forma combined statements of operations. |
(in millions) | For the Year Ended December 31, 2018 | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||||
Integration and separation costs | $ | (421 | ) | $ | (249 | ) | $ | (91 | ) |
Provision for income taxes on continuing operations(1) | $ | 98 | $ | 84 | $ | 30 | |||
(g) | Adjustment reflects the impact of certain manufacturing, leasing and supply agreements executed in connection with the separation: |
(in millions) | For the Year Ended December 31, 2018 | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||||
Costs of goods sold | $ | 11 | $ | 9 | $ | 9 | |||
Selling, general and administrative expenses | $ | 4 | $ | 4 | $ | 4 | |||
Provision for income taxes on continuing operations(1) | $ | (4 | ) | $ | (3 | ) | $ | (3 | ) |
(h) | Reflects the impact on the (benefit from) provision for income taxes on continuing operations, as if Historical DuPont and Dow AgroSciences were consolidated affiliates for the Successor periods. For the year ended December 31, 2017, an income tax benefit was recorded to reflect the removal of a $378 million valuation allowance for Dow AgroSciences that was established during the period, and which will not transfer as part of the common control combination of Dow AgroSciences. The valuation allowance was primarily related to a change in Dow AgroSciences’ ability, as a direct result of the Tax Cuts and Jobs Act (the “TCJA”), to generate and rely on sufficient levels of future foreign source income when assessing its foreign tax credits for realizability. For the year ended December 31, 2018, the consolidating adjustment reflects a benefit of $33 million resulting from the U.S. tax consolidation, inclusive of the impact of the TCJA. |
(i) | Adjustment to cash represents the following: |
(in millions) | As of December 31, 2018 | ||
Cash proceeds from related party revolving loan from Corteva | $ | 5,771 | |
Payment of fees and expenses | (79 | ) | |
Pay off or retirement of outstanding liabilities | (5,792 | ) | |
Pay off of accrued interest | (41 | ) | |
Total adjustment to cash | $ | (141 | ) |
(j) | Adjustment to short-term borrowings and capital lease obligations and long-term debt represents the following: |
(in millions) | As of December 31, 2018 | ||
Pay off of outstanding liabilities | $ | (262 | ) |
Write-off of associated fair value adjustment | (2 | ) | |
Total adjustment to short-term borrowings and capital lease obligations | $ | (264 | ) |
Pay off of outstanding liabilities | $ | (5,530 | ) |
Write-off of associated debt issuance costs | 1 | ||
Write-off of associated fair value adjustment | (76 | ) | |
Total adjustment to long-term debt | $ | (5,605 | ) |
(k) | Adjustment to include the related party term loan from Corteva of $5,771 million. |
(l) | Reflects the pay off of $41 million of accrued interest related to the above noted outstanding liabilities. |
(m) | Adjustment to derecognize a $26 million deferred tax asset associated with the pay off of the company's long-term borrowings. The deferred tax asset was recognized in relation to the fair value determination of the company's long-term borrowings as a result of the Merger and is included within deferred tax liabilities due to jurisdictional netting. |
(n) | Represents the removal of the loss on early debt extinguishment of $81 million for the year ended December 31, 2018, as it is directly attributable to the Debt Retirement Transactions and will not have a continuing impact. |
(o) | Adjustment to interest expense represents the following: |
(in millions) | For the Year Ended December 31, 2018 | For the Year Ended December 31, 2017 | For the Year Ended December 31, 2016 | ||||||
Removal of amortization of the fair value adjustment to debt(1) | $ | 87 | $ | 110 | $ | 120 | |||
Removal of Historical DuPont interest expense | (347 | ) | (322 | ) | (271 | ) | |||
Removal of amortization of Historical DuPont debt issuance costs | (1 | ) | (5 | ) | (5 | ) | |||
Interest expense associated with loan from Corteva(2) | 247 | 247 | 247 | ||||||
Total adjustment to interest expense | $ | (14 | ) | $ | 30 | $ | 91 | ||
(p) | Adjustment to record the income tax impact of the debt retirement pro forma adjustments using a blended federal and state rate of 23% for the year ended December 31, 2018 and 36% for the years ended December 31, 2017 and 2016. |
(q) | Adjustment to retained earnings for the separation pro forma adjustments represents the following: |
(in millions) | As of December 31, 2018 | ||
Removal of Telone® business | $ | (46 | ) |
Adjustment to include amount due to Dow for indemnification | (63 | ) | |
Removal of Dow AgroSciences litigation liabilities | 3 | ||
Removal of Dow AgroSciences Pension Liability (net of tax) | 60 | ||
Adjustment to include tax indemnifications and remove Dow AgroSciences tax receivables and payables | 14 | ||
Debt Retirement Transactions | (28 | ) | |
Total adjustment to retained earnings | $ | (60 | ) |
(a) | Transactions between Dow AgroSciences and Historical DuPont have been eliminated as if Dow AgroSciences and Historical DuPont were consolidated affiliates for the entire period presented. Adjustment reflects the elimination of sales and cost of goods sold of $60 million for the period January 1 through August 31, 2017 and $78 million for the year ended December 31, 2016. |
(b) | Represents the removal of cost of goods sold of $1,554 million for the year ended December 31, 2018 and $425 million for the period September 1 through December 31, 2017, related to the amortization of Historical DuPont’s agriculture business’ inventory step-up recognized in connection with the Merger, as the incremental amortization is directly attributable to the Merger and will not have a continuing impact. |
(c) | Represents estimated additional depreciation expense related to the fair value adjustment to net property, plant and equipment of Historical DuPont’s agriculture business. The table below is a summary of the information used to calculate the pro forma increase in depreciation expense. |
(in millions) | For the Period January 1 - August 31, 2017 | For the Year Ended December 31, 2016 | ||||
Cost of goods sold | $ | 20 | $ | 29 | ||
Research and development expense | 10 | 15 | ||||
Selling, general and administrative expenses | 11 | 17 | ||||
(d) | Represents estimated additional amortization expense of $122 million for the period January 1 through August 31, 2017 and $184 million for the year ended December 31, 2016 related to the fair value adjustment to Historical DuPont’s agriculture business’ intangible assets. |
(e) | Represents the elimination of one-time transaction costs directly attributable to the Merger. Transaction costs of $168 million for the year ended December 31, 2017 and $147 million for the year ended December 31, 2016 were eliminated from integration and separation costs and $10 million was eliminated from restructuring and asset-related charges (benefits) – net for the period January 1 through August 31, 2017. |
(f) | Represents a reduction of interest expense of $80 million for the period January 1 through August 31, 2017 and $120 million for the year ended December 31, 2016 related to the amortization of the fair value adjustment to Historical DuPont’s long-term debt. |
(g) | Represents the income tax effect of the pro forma adjustments related to the Merger calculated using enacted statutory tax rates applicable in each period at the legal entity in which the pre-tax adjustments were made. |
• | Internal Reorganization of Historical DuPont’s materials science and specialty products businesses, which are reflected in all periods below as discontinued operations, in accordance with ASC 205. |
• | Acquisition of Dow AgroSciences, which is reflected from September 1, 2017 onward as a transfer between entities under common control. |
(in millions) | Successor Historical DuPont | Dow AgroSciences | Discontinued Operations | Historical Adjustments(1) | Successor Historical DuPont Continuing Operations(2) | |||||||||||
Assets | As Reported | As Reported | ||||||||||||||
Current assets | ||||||||||||||||
Cash and cash equivalents | $ | 4,466 | $ | 58 | $ | (2,255 | ) | $ | — | $ | 2,269 | |||||
Marketable securities | 34 | — | (29 | ) | — | 5 | ||||||||||
Accounts and notes receivable – net | 5,534 | 2,715 | (2,635 | ) | (259 | ) | (a) (b) | 5,355 | ||||||||
Inventories | 7,407 | 1,811 | (3,917 | ) | (41 | ) | (a) | 5,260 | ||||||||
Other current assets | 1,165 | 124 | (253 | ) | 8 | (a) | 1,044 | |||||||||
Total current assets | 18,606 | 4,708 | (9,089 | ) | (292 | ) | 13,933 | |||||||||
Investment in nonconsolidated affiliates | 1,381 | 50 | (1,293 | ) | — | 138 | ||||||||||
Net property | 12,186 | 1,267 | (8,920 | ) | — | 4,533 | ||||||||||
Goodwill | 40,686 | 1,344 | (31,837 | ) | — | 10,193 | ||||||||||
Other intangible assets | 26,053 | 183 | (14,181 | ) | — | 12,055 | ||||||||||
Deferred income tax assets | 303 | 140 | (135 | ) | (2 | ) | (c) | 306 | ||||||||
Other assets | 1,810 | 81 | (103 | ) | 42 | (b) | 1,830 | |||||||||
Total assets | $ | 101,025 | $ | 7,773 | $ | (65,558 | ) | $ | (252 | ) | $ | 42,988 | ||||
Liabilities and Equity | ||||||||||||||||
Current liabilities | ||||||||||||||||
Short-term borrowings and capital lease obligations | $ | 2,160 | $ | 10 | $ | (17 | ) | $ | — | $ | 2,153 | |||||
Accounts payable | 4,982 | 1,386 | (2,197 | ) | (367 | ) | (a) | 3,804 | ||||||||
Income taxes payable | 66 | 154 | (33 | ) | — | 187 | ||||||||||
Accrued and other current liabilities | 4,233 | 665 | (918 | ) | 36 | (a)(b) | 4,016 | |||||||||
Total current liabilities | 11,441 | 2,215 | (3,165 | ) | (331 | ) | 10,160 | |||||||||
Long-term debt | ||||||||||||||||
Long-term debt | 5,812 | 5 | (33 | ) | — | 5,784 | ||||||||||
Long-term debt – related party | — | — | — | — | — | |||||||||||
Total long-term debt | 5,812 | 5 | (33 | ) | — | 5,784 | ||||||||||
Other noncurrent liabilities | ||||||||||||||||
Deferred income tax liabilities | 5,381 | 168 | (4,052 | ) | (22 | ) | (c) | 1,475 | ||||||||
Pension and other postemployment benefits – noncurrent | 6,683 | 124 | (1,131 | ) | — | 5,676 | ||||||||||
Other noncurrent obligations | 1,620 | 202 | (84 | ) | 42 | (b) | 1,780 | |||||||||
Total noncurrent liabilities | 19,496 | 499 | (5,300 | ) | 20 | 14,715 | ||||||||||
Stockholders’ equity | ||||||||||||||||
Preferred stock | 239 | — | — | — | 239 | |||||||||||
Common stock | — | — | — | — | — | |||||||||||
Additional paid-in capital | 79,790 | — | (59,589 | ) | — | 20,201 | ||||||||||
(Accumulated deficit) retained earnings | (7,669 | ) | 5,893 | 1,776 | 59 | (d) | 59 | |||||||||
Accumulated other comprehensive loss | (2,503 | ) | (858 | ) | 949 | — | (2,412 | ) | ||||||||
Total stockholders’ equity | 69,857 | 5,035 | (56,864 | ) | 59 | 18,087 | ||||||||||
Noncontrolling interests | 231 | 24 | (229 | ) | — | 26 | ||||||||||
Total equity | 70,088 | 5,059 | (57,093 | ) | 59 | 18,113 | ||||||||||
Total liabilities and equity | $ | 101,025 | $ | 7,773 | $ | (65,558 | ) | $ | (252 | ) | $ | 42,988 | ||||
(in millions) | Successor Historical DuPont | Dow AgroSciences | Discontinued Operations | Historical Adjustments(1) | Successor Historical DuPont Continuing Operations(2) | |||||||||||
As Reported | As Reported | |||||||||||||||
Net sales | $ | 26,279 | $ | 5,646 | $ | (17,275 | ) | $ | (363 | ) | (a) | $ | 14,287 | |||
Cost of goods sold | 18,182 | 3,893 | (11,594 | ) | (461 | ) | (a)(e) | 10,020 | ||||||||
Research and development expense | 1,524 | 492 | (571 | ) | (10 | ) | (e) | 1,435 | ||||||||
Selling, general and administrative expenses | 3,853 | 770 | (1,748 | ) | 26 | (e) | 2,901 | |||||||||
Amortization of intangibles | 1,281 | 22 | (912 | ) | — | 391 | ||||||||||
Restructuring and asset-related charges – net | 485 | 308 | (109 | ) | 10 | (e) | 694 | |||||||||
Integration and separation costs | 1,375 | — | (475 | ) | 92 | (e) | 992 | |||||||||
Goodwill impairment charge | 4,503 | — | — | — | 4,503 | |||||||||||
Sundry income (expense) – net | 543 | (40 | ) | (254 | ) | — | 249 | |||||||||
Loss on early extinguishment of debt | 81 | — | — | — | 81 | |||||||||||
Interest expense | 331 | 6 | — | — | 337 | |||||||||||
(Loss) income from continuing operations before income taxes | (4,793 | ) | 115 | (2,120 | ) | (20 | ) | (6,818 | ) | |||||||
Provision for (benefit from) income taxes on continuing operations | 220 | 124 | (373 | ) | (5 | ) | (a) | (34 | ) | |||||||
(Loss) income from continuing operations after income taxes | (5,013 | ) | (9 | ) | (1,747 | ) | (15 | ) | (6,784 | ) | ||||||
Net income from continuing operations attributable to noncontrolling interests | 11 | 17 | (9 | ) | — | 19 | ||||||||||
Net loss from continuing operations attributable to Historical DuPont | (5,024 | ) | (26 | ) | (1,738 | ) | (15 | ) | (6,803 | ) | ||||||
(in millions, except per share amounts) | Predecessor Historical DuPont | Discontinued Operations | Predecessor Continuing Operations(2) | Reclassification Adjustments(1) | Predecessor Historical DuPont Continuing Operations | ||||||||||
As Reported | (subtotal) | As Adjusted | |||||||||||||
Net sales | $ | 17,281 | $ | (10,387 | ) | $ | 6,894 | $ | 60 | $ | 6,954 | ||||
Cost of goods sold | 10,052 | (6,602 | ) | 3,450 | 141 | 3,591 | |||||||||
Other operating charges | 504 | (309 | ) | 195 | (195 | ) | — | ||||||||
Research and development expense | 1,022 | (388 | ) | 634 | — | 634 | |||||||||
Selling, general and administrative expenses | 3,222 | (1,340 | ) | 1,882 | (340 | ) | 1,542 | ||||||||
Amortization of intangibles | — | — | — | 40 | 40 | ||||||||||
Restructuring and asset-related charges – net | 323 | (311 | ) | 12 | — | 12 | |||||||||
Integration and separation costs | — | — | — | 354 | 354 | ||||||||||
Sundry expense – net | (113 | ) | (388 | ) | (501 | ) | (96 | ) | (597 | ) | |||||
Interest expense | 254 | — | 254 | — | 254 | ||||||||||
Income (loss) from continuing operations before income taxes | 1,791 | (1,825 | ) | (34 | ) | (36 | ) | (70 | ) | ||||||
Provision for (benefit from) income taxes on continuing operations | 149 | (543 | ) | (394 | ) | (36 | ) | (430 | ) | ||||||
Income from continuing operations after income taxes | 1,642 | (1,282 | ) | 360 | — | 360 | |||||||||
Net income from continuing operations attributable to noncontrolling interests | 18 | (17 | ) | 1 | — | 1 | |||||||||
Net income from continuing operations attributable to Historical DuPont | 1,624 | (1,265 | ) | 359 | — | 359 | |||||||||
Preferred stock dividends | 7 | — | 7 | — | 7 | ||||||||||
Net income from continuing operations attributable to Historical DuPont common stockholders | $ | 1,617 | $ | (1,265 | ) | $ | 352 | $ | — | $ | 352 | ||||
Earnings per common share from continuing operations: | |||||||||||||||
Basic | $ | 1.86 | $ | 0.41 | |||||||||||
Diluted | $ | 1.85 | $ | 0.40 | |||||||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 867.9 | 867.9 | |||||||||||||
Diluted | 872.4 | 872.4 | |||||||||||||
(in millions) | Successor Historical DuPont | Dow AgroSciences(1) | Discontinued Operations | Historical Adjustments(2) | Successor Historical DuPont Continuing Operations(3) | |||||||||||
As Reported | ||||||||||||||||
Net sales | $ | 7,053 | $ | 2,214 | $ | (5,455 | ) | $ | (27 | ) | (a) | $ | 3,785 | |||
Cost of goods sold | 6,240 | 1,510 | (4,753 | ) | (61 | ) | (a) (e) | 2,936 | ||||||||
Research and development expense | 492 | 211 | (187 | ) | (5 | ) | (e) | 511 | ||||||||
Selling, general and administrative expenses | 1,141 | 298 | (557 | ) | (12 | ) | (e) | 870 | ||||||||
Amortization of intangibles | 389 | 7 | (299 | ) | — | 97 | ||||||||||
Restructuring and asset-related charges – net | 180 | 182 | (109 | ) | 17 | (e) | 270 | |||||||||
Integration and separation costs | 314 | — | (110 | ) | 51 | (e) | 255 | |||||||||
Sundry income – net | 224 | 647 | (66 | ) | — | 805 | ||||||||||
Interest expense | 107 | 8 | — | — | 115 | |||||||||||
(Loss) income from continuing operations before income taxes | (1,586 | ) | 645 | 494 | (17 | ) | (464 | ) | ||||||||
(Benefit from) provision for income taxes on continuing operations | (2,673 | ) | 471 | 1 | (6 | ) | (a) | (2,207 | ) | |||||||
Income from continuing operations after income taxes | 1,087 | 174 | 493 | (11 | ) | 1,743 | ||||||||||
Net income from continuing operations attributable to noncontrolling interests | — | 7 | — | — | 7 | |||||||||||
Net income from continuing operations attributable to Historical DuPont | 1,087 | 167 | 493 | (11 | ) | 1,736 | ||||||||||
(in millions, except per share amounts) | Predecessor Historical DuPont | Discontinued Operations | Predecessor Continuing Operations(2) | Reclassification Adjustments(1) | Predecessor Historical DuPont Continuing Operations | ||||||||||
As Reported | (subtotal) | As Adjusted | |||||||||||||
Net sales | $ | 23,209 | $ | (15,076 | ) | $ | 8,133 | $ | 132 | $ | 8,265 | ||||
Cost of goods sold | 13,937 | (9,550 | ) | 4,387 | 216 | 4,603 | |||||||||
Other operating charges | 667 | (416 | ) | 251 | (251 | ) | — | ||||||||
Research and development expense | 1,496 | (571 | ) | 925 | — | 925 | |||||||||
Selling, general and administrative expenses | 4,127 | (1,766 | ) | 2,361 | (295 | ) | 2,066 | ||||||||
Amortization of intangibles | — | — | — | 45 | 45 | ||||||||||
Restructuring and asset-related charges – net | 556 | (118 | ) | 438 | — | 438 | |||||||||
Integration and separation costs | — | — | — | 285 | 285 | ||||||||||
Sundry income (expense) – net | 667 | (591 | ) | 76 | (124 | ) | (48 | ) | |||||||
Interest expense | 370 | — | 370 | — | 370 | ||||||||||
Income (loss) from continuing operations before income taxes | 2,723 | (3,246 | ) | (523 | ) | 8 | (515 | ) | |||||||
Provision for (benefit from) income taxes on continuing operations | 641 | (924 | ) | (283 | ) | 8 | (275 | ) | |||||||
Income (loss) from continuing operations after income taxes | 2,082 | (2,322 | ) | (240 | ) | — | (240 | ) | |||||||
Net income from continuing operations attributable to noncontrolling interests | 10 | (9 | ) | 1 | — | 1 | |||||||||
Net income (loss) from continuing operations attributable to Historical DuPont | 2,072 | (2,313 | ) | (241 | ) | — | (241 | ) | |||||||
Preferred stock dividends | 10 | — | 10 | — | 10 | ||||||||||
Net income (loss) from continuing operations attributable to Historical DuPont common stockholders | $ | 2,062 | $ | (2,313 | ) | $ | (251 | ) | $ | — | $ | (251 | ) | ||
Earnings (loss) per common share from continuing operations: | |||||||||||||||
Basic | $ | 2.36 | $ | (0.29 | ) | ||||||||||
Diluted(3) | $ | 2.35 | $ | (0.29 | ) | ||||||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 872.6 | 872.6 | |||||||||||||
Diluted(3) | 877.0 | 872.6 | |||||||||||||
(a) | Adjustment primarily relates to the elimination of intercompany transactions between Historical DuPont and Dow AgroSciences for the Successor periods, as if they were combined affiliates. The following tables summarize the intercompany elimination adjustments in the unaudited pro forma combined balance sheet and the unaudited pro forma combined statements of operations: |
(in millions) | As of December 31, 2018 | ||
Accounts and notes receivable – net | $ | (284 | ) |
Inventories | (41 | ) | |
Other current assets | 8 | ||
Total current assets | $ | (317 | ) |
Accounts payable | $ | (367 | ) |
Accrued and other current liabilities | 11 | ||
Total current liabilities | $ | (356 | ) |
(in millions) | For the Year Ended December 31, 2018 | For the Period September 1 - December 31, 2017 | ||||
Net sales | $ | (363 | ) | $ | (27 | ) |
Cost of goods sold | (343 | ) | (10 | ) | ||
(Loss) income from continuing operations before income taxes | (20 | ) | (17 | ) | ||
(Benefit from) income taxes on continuing operations(1) | (5 | ) | (6 | ) | ||
(Loss) income from continuing operations after income taxes | $ | (15 | ) | $ | (11 | ) |
(b) | Historical DuPont will be indemnified against certain litigation, environmental and employee-related liabilities that arose prior to the distribution. Within the unaudited pro forma combined balance sheet, these liabilities are included in the Successor Historical DuPont column and are removed in the Discontinued Operations column. The indemnified liabilities of $25 million and $42 million are included in accrued and other current liabilities and other noncurrent obligations, respectively, and the related indemnification assets of $25 million and $42 million are included in accounts and notes receivable – net and other assets, respectively. |
(c) | Reflects the impact on deferred tax assets and deferred tax liabilities from jurisdictional netting and a reduction in deferred tax asset valuation allowances due to the assessment of Historical DuPont and Dow AgroSciences deferred tax assets, as if they were consolidated affiliates. |
(d) | Reflects the impact to Historical DuPont's retained earnings from pro forma adjustments described above. |
(e) | In order to align the financial statement presentation of Dow AgroSciences to that of Historical DuPont’s continuing operations, certain reclassification adjustments have been made to the unaudited pro forma combined statements of operations as follows: |
(in millions) | For the Year Ended December 31, 2018 | For the Period September 1 - December 31, 2017 | ||||||||||
Cost of goods sold | $ | (5 | ) | $ | (9 | ) | ||||||
Research and development expense | $ | (1 | ) | $ | (1 | ) | ||||||
Selling, general and administrative expenses | $ | (4 | ) | $ | (7 | ) | ||||||
Restructuring and asset-related charges – net | $ | 10 | $ | 17 | ||||||||
Cost of goods sold | $ | (46 | ) | $ | (27 | ) | ||||||
Research and development expense | $ | (9 | ) | $ | (4 | ) | ||||||
Selling, general and administrative expenses | $ | (37 | ) | $ | (20 | ) | ||||||
Integration and separation costs | $ | 92 | $ | 51 | ||||||||
Cost of goods sold(1) | $ | (67 | ) | $ | (15 | ) | ||||||
Selling, general and administrative expenses(1) | $ | 67 | $ | 15 | ||||||||
(in millions) | For the Period January 1 - August 31, 2017 | For the Year Ended December 31, 2016 | ||||||||||
Other operating charges (Predecessor Historical DuPont continuing operations) | $ | (195 | ) | $ | (251 | ) | ||||||
Cost of goods sold | $ | 156 | $ | 225 | ||||||||
Selling, general and administrative expenses | $ | 39 | $ | 26 | ||||||||
Sundry (expense) income – net (Predecessor Historical DuPont continuing operations) | $ | (96 | ) | $ | (124 | ) | ||||||
Net sales | $ | 60 | $ | 132 | ||||||||
Benefit from (provision for) income taxes on continuing operations(1) | $ | 36 | $ | (8 | ) | |||||||
Predecessor Historical DuPont amortization of intangibles, continuing operations: | ||||||||||||
Cost of goods sold | $ | (15 | ) | $ | (9 | ) | ||||||
Selling, general and administrative expenses | $ | (25 | ) | $ | (36 | ) | ||||||
Amortization of intangibles | $ | 40 | $ | 45 | ||||||||
Predecessor Historical DuPont integration and separation costs, continuing operations: | ||||||||||||
Selling, general and administrative expenses | $ | (354 | ) | $ | (285 | ) | ||||||
Integration and separation costs(2) | $ | 354 | $ | 285 | ||||||||